President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

List includes medications for diabetes, cancer, arthritis, and more ...

Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

In his push to “lower prescription drug prices for all Americans,” President Donald Trump is calling on three specific ...

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

Patients needing prescription medications are facing sticker shock and some people are paying more than others for the exact ...